Overall, BET inhibitors restores T cell function by downregulating IC molecules on T cells and suppressing PD-L1 on tumors, enhancing cytotoxicity and reducing tumor progression (62, 140, 149) as shown in Figure 4. The gene discussed is CD274; the disease is neoplasm.